iRadimed (IRMD) Stock Chart & Stock Price History $70.38 +0.23 (+0.33%) Closing price 04:00 PM EasternExtended Trading$70.44 +0.06 (+0.08%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock iRadimed Stock Price Performance The iRadimed (IRMD) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 55.95%, with a year-to-date return of 27.96%. In the past month, the stock has increased 21.70%, reflecting recent market activity. As of the latest close, iRadimed traded at $70.15 with a market cap of $892.31 million and volume of 72,086 shares. Five years ago, the stock traded at $22.01, representing a 219.76% increase over that period. At the time, it had a market cap of $266.47 million and a volume of 22,728 shares. Receive IRMD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for iRadimed and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.64%1 Month Performance+21.70%3 Month Performance+30.67%Year-To-Date Performance+27.96%1 Year Performance+55.95%5 Year Performance+219.76% IRMD Stock Chart for Friday, August, 15, 2025 IRMD Chart by TradingView iRadimed Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/15/2025$70.15$70.38+0.33%$70.82$69.8851,125 shs$895.23 million08/14/2025$71.00$70.15-1.20%$71.42$69.4472,086 shs$892.31 million08/13/2025$73.00$71.00-2.74%$73.47$70.82130,467 shs$903.12 million08/12/2025$70.00$73.00+4.29%$73.29$69.7044,310 shs$928.56 million08/11/2025$69.93$70.00+0.10%$70.58$69.3134,633 shs$890.40 million08/08/2025$68.97$69.93+1.39%$69.97$68.7028,321 shs$889.51 million08/07/2025$70.32$68.97-1.92%$70.43$67.5150,732 shs$877.30 million08/06/2025$69.57$70.32+1.08%$71.00$69.0556,629 shs$894.47 million08/05/2025$70.69$69.57-1.58%$71.00$68.0790,379 shs$884.93 million08/04/2025$66.17$70.69+6.83%$71.91$66.78128,104 shs$899.18 million Get the Latest News and Ratings for IRMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for iRadimed and its competitors with MarketBeat's FREE daily newsletter. 08/01/2025$58.34$66.17+13.42%$66.50$59.00108,444 shs$841.68 million07/31/2025$58.37$58.34-0.05%$59.06$57.8374,229 shs$741.79 million07/30/2025$57.80$58.37+0.99%$58.73$57.5841,262 shs$742.47 million07/29/2025$57.11$57.80+1.21%$58.51$57.5329,581 shs$735.22 million07/28/2025$56.32$57.11+1.40%$58.08$56.1530,634 shs$726.15 million07/25/2025$56.60$56.32-0.49%$58.00$55.1130,681 shs$716.11 million07/24/2025$57.00$56.60-0.70%$56.96$56.4319,701 shs$719.95 million07/23/2025$56.30$57.00+1.24%$57.36$55.7736,425 shs$725.04 million07/22/2025$56.19$56.30+0.20%$56.99$56.0539,639 shs$715.85 million07/21/2025$56.69$56.19-0.88%$56.73$56.0327,018 shs$714.74 million07/18/2025$57.45$56.69-1.32%$58.43$56.3730,893 shs$721.10 million07/17/2025$57.91$57.45-0.79%$58.17$57.1828,100 shs$730.76 million07/16/2025$57.83$57.91+0.14%$58.44$56.8644,735 shs$736.33 million07/15/2025$58.07$57.83-0.41%$58.99$57.4653,896 shs$735.60 million07/14/2025$57.57$58.07+0.87%$58.65$57.4632,877 shs$738.65 million Related Companies NVST Stock Chart LIVN Stock Chart WRBY Stock Chart INSP Stock Chart PRCT Stock Chart LMAT Stock Chart EYE Stock Chart AORT Stock Chart LQDA Stock Chart CNMD Stock Chart Receive IRMD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for iRadimed and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IRMD) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iRadimed Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share iRadimed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access